Biomarkers in Infection
NCT02545478 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4200
Last updated 2026-04-15
Summary
The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
Conditions
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
lead OTHER
Principal Investigators
-
Nathan Shapiro, MD MPH · Beth Israel Deaconess Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2030-12-31
- Completion
- 2031-12-31
Countries
- United States
Study Locations
More Related Trials
-
Biological Markers to Identify Early Sepsis and Acute Lung Injury
NCT00825357 ·Status: COMPLETED
-
Early Identification and Prognosis Prediction of Sepsis Through Multiomics
NCT05305469 ·Status: RECRUITING
-
Mechanisms of Precise Immune Cell Phenotyping and Prognostic Prediction in Severe Infection
NCT07332793 ·Status: NOT_YET_RECRUITING
-
Early Predictors of Prognostic Course in Patients With COVID-19 in Critical or Semi-intensive Area.
NCT04873388 ·Status: UNKNOWN
-
Microcirculatory Alteration and Biomarkers: New Approach for Early Assessment of Septic Multi-organ Dysfunction
NCT02426645 ·Status: UNKNOWN
-
Sepsis-damaged Organs-double-markers Identification of Organ Failure Using Fluorescent Nanoparticle Tracking Analysis
NCT03222986 ·Status: COMPLETED
-
Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock
NCT02163473 ·Status: COMPLETED
-
Diagnostic of Infections Following Major Abdominal Surgery and Burn Injury
NCT01055587 ·Status: COMPLETED
-
Predictors of Respiratory Failure in SARS-Cov-2 Infection
NCT04316949 ·Status: UNKNOWN
-
Multiple Biomarkers in ICU Sepsis Patients
NCT03802136 ·Status: UNKNOWN
-
Study of Immunosuppression Biomarkers Acquired in Patients Hospitalized in Intensive Care Unit
NCT02881268 ·Status: COMPLETED
-
Early Diagnostic Biomarkers of Sepsis
NCT05112406 ·Status: UNKNOWN
-
Alpha-1-acid Glycoprotein as a Biomarker of Developmental Diagnosing and Monitoring Effectiveness in Sepsis
NCT01838525 ·Status: UNKNOWN
-
System-level Monitoring of Immune Activation Concerning Susceptibility to Sepsis in Trauma Patients
NCT01472952 ·Status: WITHDRAWN
-
Sepsis Metabolomics
NCT01649440 ·Status: COMPLETED
-
Systems Analysis of Antigen Presenting Cells in Human Sepsis
NCT03788772 ·Status: COMPLETED ·Phase: NA
-
Establishment of Risk Indicators and Early Warning System in Infection Patients
NCT05099120 ·Status: UNKNOWN
-
PICS: Subtitle Cardiac Dysfunction in Older Sepsis Survivors
NCT02276417 ·Status: ACTIVE_NOT_RECRUITING
-
The Extended Study of Prevalence of Infection in Intensive Care IV
NCT07309549 ·Status: NOT_YET_RECRUITING
-
Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal Origin
NCT01530932 ·Status: COMPLETED
-
MiRNAs Evaluate the Prognosis of Sepsis by Dynamic Study
NCT01459822 ·Status: UNKNOWN
-
Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis
NCT03244293 ·Status: RECRUITING
-
CRP,CRP/Alb Ratio, N/L Ratio in Predictors of Both Systemic Infection and Survival in Patient with Sepsis in Assiut University Hospitals
NCT06586372 ·Status: NOT_YET_RECRUITING
-
Blood Indices of Systemic Inflammation in Critically Ill Patients With Abdominal Sepsis
NCT06095830 ·Status: NOT_YET_RECRUITING
-
CharacterisatiON of carDiac funCTion in Intensive Care Unit Survivors of Sepsis.
NCT05633290 ·Status: UNKNOWN